7TM Pharma has initiated Phase I/IIa clinical trial with TM30339 for the treatment of obesity and related metabolic disorders
Read more… Tuesday, September 02, 2008
7TM Pharma receives milestone payment from asthma and allergy collaboration
Read more… Wednesday, April 16, 2008
7TM Pharma enters into drug discovery collaboration with Dr. Reddy’s on selected drug targets
Read more… Monday, March 10, 2008
Positive results from two clinical Phase I studies with the drug candidate TM30339 for the treatment of obesity
Read more… Wednesday, February 27, 2008
7TM Pharma announces the selection of a new pre-clinical development candidate, TM38837, for treatment of obesity and Type 2 diabetes
Read more… Wednesday, February 06, 2008
Results from a Phase I/II clinical study with the drug candidate Obinepitide for the treatment of obesity
Read more… Wednesday, November 28, 2007
7TM Pharma Appoints New Chairman of the Board
Read more… Thursday, November 01, 2007
7TM Pharma hires experienced Director of Business Development and Medical Director
Read more… Thursday, September 27, 2007
7TM Pharma obtains patent protection for the use of both Obinepitide and TM30339 in the treatment of obesity
Read more… Tuesday, June 26, 2007
7TM Pharma initiates Phase II clinical study with the drug candidate Obinepitide for the treatment of obesity
Read more… Tuesday, June 12, 2007
7TM Pharma raises DKK 123 million in financing round
Read more… Thursday, June 07, 2007
7TM Pharma advances the next first-in-class obesity compound into clinical development
Read more… Thursday, March 08, 2007
7TM Pharma acquires CareX SA
Read more… Wednesday, May 24, 2006
7TM Pharma’s strong progress attracts EUR 19 million in a Series C financing round
Read more… Friday, March 31, 2006
7TM Pharma’s new first-in-class anti-obesity drug completes Phase I/II clinical studies
Read more… Monday, March 20, 2006
7TM Pharma receives milestone payment in collaboration with Procter & Gamble Pharmaceuticals
Read more… Wednesday, February 22, 2006
7TM Pharma strengthens its organization
Read more… Wednesday, October 05, 2005
Selection of a new development candidate TM30339 for treatment of obesity
Read more… Thursday, August 18, 2005
7TM Pharma adds Johnson & Johnson Development Corporation to its investor group
Read more… Thursday, August 18, 2005
7TM Pharma initiates Phase I/II clinical studies with TM30338 for the treatment of obesity
Read more… Thursday, July 07, 2005
7TM Pharma Enters Discovery Collaboration with Ortho-McNeil Pharmaceutical To Develop Novel Compounds for Asthma and Allergic Diseases
Read more… Wednesday, June 08, 2005
7TM Pharma signs research agreement with Procter & Gamble
Read more… Tuesday, April 12, 2005
7TM Pharma A/S raises Euro 6 million
Read more… Thursday, October 28, 2004
7TM Pharma announces the selection of a pre-clinical candidate for treatment of obesity
Read more… Thursday, October 28, 2004
7TM Pharma announces an additional collaboration with Synaptic
Read more… Monday, September 06, 2004
7TM Pharma signs research agreement with AstraZeneca
Read more… Monday, August 30, 2004
7TM Pharma and Synaptic Announces Collaborative Agreement on Novel Drug Targets
Read more… Tuesday, January 13, 2004